| 0.9419 0.001 (0.15%) | 10-22 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 1.28 | 1-year : | 1.47 |
| Resists | First : | 1.1 | Second : | 1.25 |
| Pivot price | 1 |
|||
| Supports | First : | 0.85 | Second : | 0.7 |
| MAs | MA(5) : | 0.95 |
MA(20) : | 1.01 |
| MA(100) : | 1.56 |
MA(250) : | 2.49 |
|
| MACD | MACD : | -0.1  |
Signal : | -0.1 |
| %K %D | K(14,3) : | 32.5 |
D(3) : | 34.5 |
| RSI | RSI(14): 40.4 |
|||
| 52-week | High : | 6.07 | Low : | 0.7 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ AGL ] has closed above bottom band by 28.8%. Bollinger Bands are 44.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 41 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 0.97 - 0.98 | 0.98 - 0.99 |
| Low: | 0.92 - 0.92 | 0.92 - 0.93 |
| Close: | 0.93 - 0.94 | 0.94 - 0.95 |
agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.
Tue, 21 Oct 2025
AGL Investor News: If You Have Suffered Losses in agilon - GlobeNewswire
Tue, 21 Oct 2025
agilon health, inc. (AGL) Stock Analysis: Navigating Challenges with a 24.59% Potential Upside - DirectorsTalk Interviews
Tue, 14 Oct 2025
agilon health, inc. (AGL) Stock Analysis: Exploring 36% Potential Upside Amidst Healthcare Challenges - DirectorsTalk Interviews
Tue, 07 Oct 2025
Wells Fargo Maintains agilon health (AGL) Overweight Recommendation - Nasdaq
Mon, 06 Oct 2025
agilon health Sets Date to Report Third Quarter 2025 Financial Results - Business Wire
Tue, 30 Sep 2025
agilon health, inc. (AGL) Stock Analysis: Eyeing a 33.75% Upside in a Challenging Market Landscape - DirectorsTalk Interviews
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Care Facilities
|
|
| Shares Out | 414 (M) |
| Shares Float | 286 (M) |
| Held by Insiders | 2 (%) |
| Held by Institutions | 93.3 (%) |
| Shares Short | 19,790 (K) |
| Shares Short P.Month | 18,170 (K) |
| EPS | -0.8 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.99 |
| Profit Margin | -5.4 % |
| Operating Margin | -8.4 % |
| Return on Assets (ttm) | -12.1 % |
| Return on Equity (ttm) | -60.7 % |
| Qtrly Rev. Growth | -6 % |
| Gross Profit (p.s.) | -0.26 |
| Sales Per Share | 14.23 |
| EBITDA (p.s.) | -0.84 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -58 (M) |
| Levered Free Cash Flow | -4 (M) |
| PE Ratio | -1.2 |
| PEG Ratio | 0 |
| Price to Book value | 0.95 |
| Price to Sales | 0.06 |
| Price to Cash Flow | -6.69 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|